Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

CD38 Expression As an Additional Prognostic Marker in Mantle Cell Lymphoma

Matteo D'Addona, Luca Pezzullo, Valentina Giudice, Danilo De Novellis, Idalucia Ferrara, Raffaele Fontana, Roberto Guariglia, Serena Luponio, Laura Mettivier, Maria Carmen Martorelli, Andrea Gigantiello, Denise Morini, Michela Rizzo, Maria Teresa Buonanno, Giuseppe Ciancia, Marisa Gorrese, Bianca Serio, Carmine Selleri

Blood (2024) 144 (Supplement 1): 6250.

https://doi.org/10.1182/blood-2024-198812

Published: 2024

Journal Articles

Is Interim PET a Useful and Used Tool in Classical Hodgkin Lymphoma? Results from a Retrospective Multicenter Italian Experience

Vittorio Ruggero Zilioli, Emanuele Cencini, Sonya De Lorenzo, Luca Pezzullo, Michele Merli, Flavia Rivellini, Cristina Muzi, Emiliano Barbieri, Luigi Marcheselli, Stefano Luminari

Blood (2023) 142 (Supplement 1): 4452.

https://doi.org/10.1182/blood-2023-182297

Published: 2023

Journal Articles

Hemopoiesis and Immune Cell Perturbations during Venetoclax Plus Azacytidine Treatment in Acute Myeloid Leukemia

Valentina Giudice, Idalucia Ferrara, Marisa Gorrese, Francesca D'Alto, Roberto Guariglia, Serena Luponio, Luca Pezzullo, Laura Mettivier, Angela Bertolini, Matteo D'Addona, Danilo De Novellis, Bianca Cuffa, Bianca Serio, Carmine Selleri

Blood (2021) 138 (Supplement 1): 4339.

https://doi.org/10.1182/blood-2021-150484

Published: 2021

Journal Articles

Adding Hydroxyurea in Combination with Ruxolitinib Improves Clinical Responses in Hyperproliferative Forms of Myelofibrosis

Novella Pugliese, MD, Claudia Giordano, MD, Davide Nappi, Luigia Luciano, MD, Claudio Cerchione, MD PhD, Mario Annunziata, Beniamino Casale, Elena Crisà, MD, Maria Rosaria Villa, Luca Pezzullo, Mariolina Iovine, Marco Picardi, MD, Francesco Grimaldi, MD, Maria Monteverde, Fabrizio Pane

Blood (2018) 132 (Supplement 1): 4290.

https://doi.org/10.1182/blood-2018-99-118986

Published: 2018

Journal Articles

The Role of B Regulatory Cells in the Immunological Escape of Tumor Cells in Hodgkin Lymphoma

Valentina Giudice, MD, Monia Rocco, PhD, Giancarlo Villani, Rosa Rosamilio, MD, Luca Pezzullo, MD, Bianca Serio, MD, Idalucia Ferrara, MD, Carmine Selleri, MD

Blood (2016) 128 (22): 1768.

https://doi.org/10.1182/blood.V128.22.1768.1768

Published: 2016

Journal Articles

How to Improve the Definition of Chronic Lymphocytic Leukemia Outcome Using a Simple Flow Cytometric Score Based on CD49d and Homing Marker Expression

Valentina Giudice, MD, Monia Rocco, PhD, Luca Pezzullo, MD, Giancarlo Villani, Rosa Rosamilio, MD, Luigi Marino, Silvana Annunziata, MD, Raffaele Fontana, MD, Idalucia Ferrara, MD, Bianca Serio, MD, Carmine Selleri, MD

Blood (2016) 128 (22): 5567.

https://doi.org/10.1182/blood.V128.22.5567.5567

Published: 2016

Journal Articles

Cytomegalovirus Reactivation Prophylaxis With Low Dose Valgancyclovir After Hematopoietic Stem Cell Transplantation

Bianca Serio, MD, Luca Pezzullo, MD, Raffaele Fontana, MD, Silvana Annunziata, MD, Rosa Rosamilio, Idalucia Ferrara, MD, Monia Rocco, Valentina Giudice, Mariarosaria Sessa, Ciro De Luca, Carmine Selleri, MD

Blood (2013) 122 (21): 4578.

https://doi.org/10.1182/blood.V122.21.4578.4578

Published: 2013

Journal Articles

Induction Therapy With Continuous Alternate-Day Low Dose Lenalidomide Combined With Low-Dose Prednisone In Octogenarian Multiple Myeloma Patients

Luca Pezzullo, MD, Bianca Serio, MD, Raffaele Fontana, MD,, Idalucia Ferrara, MD, Mariarosaria Sessa, Valentina Giudice, Giancarlo Villani, Monia Rocco, Carmine Selleri, MD

Blood (2013) 122 (21): 5394.

https://doi.org/10.1182/blood.V122.21.5394.5394

Published: 2013

Journal Articles

Efficacy of Nilotinib in EARLY Chronic PHASE CML Patients WHO Have Suboptimal Cytogenetic or Molecular Response to Imatinib. A Multicentric Retrospective Study

Luigia Luciano, MD, Elisa Seneca, MD, Mario Annunziata, MD, Luca Pezzullo, MD, Paolo Danise, MD, Ursula Sessa, MD, Fausto Palmieri, MD, Mariolina Iovine, MD, Roberto Vallone, MD, Fabrizio Pane

Blood (2012) 120 (21): 4454.

https://doi.org/10.1182/blood.V120.21.4454.4454

Published: 2012

Journal Articles

Purging in Vivo and Auto-Transplantation in Patients with Poor Prognosis Lymphoproliferative Disease

Vincenzo Mettivier, Luca Pezzullo, Olimpia Finizio, Lucia Bene, Stefano Rocco, Pellegrino Musto, MD, Giuseppe Nunziata, Laura Mettivier

Blood (2008) 112 (11): 4446.

https://doi.org/10.1182/blood.V112.11.4446.4446

Published: 2008

Journal Articles

Six Years of Experience and Outcome with Maintenance Therapy with Very Low Dose Thalidomide after Auto-SCT in Multiple Myeloma

Vincenzo Mettivier, Luca Pezzullo, Stefano Rocco, Olimpia Finizio, Pellegrino Musto, MD, Giuseppe Nunziata, Lucia Bene, Laura Mettivier

Blood (2008) 112 (11): 5208.

https://doi.org/10.1182/blood.V112.11.5208.5208

Published: 2008

Journal Articles

Radioimmunotherapy ( 90 Y-Zevalin®) Combined with BEAM Conditioning Regimen and Autologous Stem Cell Transplantation for the Treatment of Non Hodgkin Lymphomas: Results of An Italian Multicenter Study.

Blood (2008) 112 (11): 1144.

https://doi.org/10.1182/blood.V112.11.1144.1144

Published: 2008

Journal Articles

Front-Line Therapy of Acute Myeloid Leukemia in Elderly Patients. Safety and Efficacy of Two Different Schedules of Fludarabine-Based Regimens.

Stefano Rocco, MD, Giancarla Pricolo, Luca Pezzullo, MD, Antonella Prudenzano, Olimpia Finizio, MD, Francesco Casulli, MD, Lucia Bene, MD, Carlo De Rosa, MD, Vincenzo Mettivier, MD, Patrizio Mazza, MD

Blood (2005) 106 (11): 4637.

https://doi.org/10.1182/blood.V106.11.4637.4637

Published: 2005

Journal Articles

Acute Myeloid Leukemia in the Elderly, Intensive or Maintenance Therapy? Our Experience in Patients over 65 Years.

Vincenzo Mettivier, MD, Luca Pezzullo, MD, Stefano Rocco, MD, Olimpia Finizio, MD, Lucia Bene, MD, Carlo De Rosa, MD, Giuseppe Rodolfo Nunziata, MD, Marina Liberati, MD

Blood (2005) 106 (11): 4640.

https://doi.org/10.1182/blood.V106.11.4640.4640

Published: 2005

Journal Articles

Ca 15-3 a Marker for the Megaloblastic Anaemia?.

Vincenzo Mettivier, MD, Luca Pezzullo, MD, Olimpia Finizio, MD, Stefano Rocco, MD, Lucia Bene, MD, Carlo De Rosa, MD

Blood (2005) 106 (11): 3733.

https://doi.org/10.1182/blood.V106.11.3733.3733

Published: 2005

NARROW

CD38 Expression As an Additional Prognostic Marker in Mantle Cell Lymphoma

Is Interim PET a Useful and Used Tool in Classical Hodgkin Lymphoma? Results from a Retrospective Multicenter Italian Experience

Hemopoiesis and Immune Cell Perturbations during Venetoclax Plus Azacytidine Treatment in Acute Myeloid Leukemia

Adding Hydroxyurea in Combination with Ruxolitinib Improves Clinical Responses in Hyperproliferative Forms of Myelofibrosis

The Role of B Regulatory Cells in the Immunological Escape of Tumor Cells in Hodgkin Lymphoma

How to Improve the Definition of Chronic Lymphocytic Leukemia Outcome Using a Simple Flow Cytometric Score Based on CD49d and Homing Marker Expression

Cytomegalovirus Reactivation Prophylaxis With Low Dose Valgancyclovir After Hematopoietic Stem Cell Transplantation

Induction Therapy With Continuous Alternate-Day Low Dose Lenalidomide Combined With Low-Dose Prednisone In Octogenarian Multiple Myeloma Patients

Efficacy of Nilotinib in EARLY Chronic PHASE CML Patients WHO Have Suboptimal Cytogenetic or Molecular Response to Imatinib. A Multicentric Retrospective Study

Purging in Vivo and Auto-Transplantation in Patients with Poor Prognosis Lymphoproliferative Disease

Six Years of Experience and Outcome with Maintenance Therapy with Very Low Dose Thalidomide after Auto-SCT in Multiple Myeloma

Radioimmunotherapy ( 90 Y-Zevalin®) Combined with BEAM Conditioning Regimen and Autologous Stem Cell Transplantation for the Treatment of Non Hodgkin Lymphomas: Results of An Italian Multicenter Study.

Front-Line Therapy of Acute Myeloid Leukemia in Elderly Patients. Safety and Efficacy of Two Different Schedules of Fludarabine-Based Regimens.

Acute Myeloid Leukemia in the Elderly, Intensive or Maintenance Therapy? Our Experience in Patients over 65 Years.

Ca 15-3 a Marker for the Megaloblastic Anaemia?.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only